Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma (Q59571646)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma |
article |
Statements
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma (English)
Neeraj Agarwal
David Cella
Akintunde Bello
Beata Korytowsky
Jinyu Yuan
Olga Valota
Bridget Martell
Subramanian Hariharan
Thomas E Hutson
Mark R Olsen
Gary R Hudes
John M Burke
William J Edenfield
John A Thompson
Robert A Figlin